iNmed

inmed

iNmed
We’re building a technologically advanced cannabinoid pharmaceutical company unlike any other
InMed is a biopharmaceutical company that specializes in the discovery and development of novel, cannabinoid-based therapeutics for the treatment of diseases with high unmet medical need.

InMed employs a highly scientific approach to designing and developing medicines, which will help unlock the full potential of cannabinoid pharmaceuticals. One proprietary technology is our robust microbial-based biosynthesis process designed to enable the manufacturing of a wide range of cannabinoids typically found in trace amounts from natural sources.

InMed’s cannabinoid compounds are designed to be bio-identical to the naturally-occurring cannabinoids. The process is envisioned to offer cost and time savings and superior ease, control and quality of manufacturing when compared to alternative methods.

Showing all 3 results